This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
However, about 17 percent of individuals prescribed a placebo kept about 80 percent of their original weight loss, a new trial shows.
The decision will makes it easier for insurance coverage for millions struggling with excess weight.
